Swiss Man Charged in $4.7 Million Sanofi Insider Scheme

(Bloomberg) -- A Swiss man was charged in the U.S. with illegally making more than $4.7 million in trading on an insider tip about Sanofi’s 2018 acquisition of Bioverativ, a developer of hemophilia...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.